Real-time
Other stock markets
|
5-day change | 1st Jan Change | ||
88.27 EUR | +0.11% | +1.72% | -1.65% |
09:04am | Sanofi: positive phase III data in IPT | CF |
07:45am | Sanofi Reports Positive Results from Phase 3 Trial of Rilzabrutinib for Immune Thrombocytopenia | MT |
Filters
- Stock Market
- Equities
- SAN Stock
- News Sanofi